Loncar China Biopharma ETF (CHNA) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Loncar China Biopharma ETF Short Interest Data

Current Short Volume
500 shares
Previous Short Volume
500 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$7,180.00
Short Interest Ratio / Days to Cover
0.5
Last Record Date
September 30, 2022
Outstanding Shares
1,430,000 shares
Percentage of Shares Shorted
0.03%
Today's Trading Volume
100 shares
Average Trading Volume
538 shares
Today's Volume Vs. Average
19%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Loncar China Biopharma ETF ?

Sign up to receive the latest short interest report for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CHNA Short Interest Over Time

CHNA Days to Cover Over Time

CHNA Percentage of Float Shorted Over Time

Loncar China Biopharma ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/2022500 shares $7,180.00 No ChangeN/A0.5 $14.36
9/15/2022500 shares $8,020.00 -16.7%N/A0.3 $16.04
8/31/2022600 shares $10,662.00 No ChangeN/A0.3 $17.77
8/15/2022600 shares $11,061.60 -40.0%N/A0.3 $18.44
7/31/20221,000 shares $18,710.00 -82.1%N/A0.6 $18.71
7/15/20225,600 shares $110,320.00 No ChangeN/A2 $19.70
11/30/2021500 shares $16,670.00 -54.6%N/A0.2 $33.34
11/15/20211,100 shares $37,191.00 +120.0%N/A0.4 $33.81
10/29/2021500 shares $16,697.50 -54.6%N/A0.2 $33.40
10/15/20211,100 shares $38,874.11 No ChangeN/A0.4 $35.34
9/30/20211,100 shares $41,019.00 No ChangeN/A0.3 $37.29
9/15/20211,100 shares $42,729.28 -21.4%N/A0.2 $38.84
8/31/20211,400 shares $53,018.00 -22.2%N/A0.3 $37.87
8/13/20211,800 shares $72,414.00 -40.0%N/A0.3 $40.23
7/30/20213,000 shares $124,770.00 -31.8%N/A0.6 $41.59
7/15/20214,400 shares $200,772.00 +10.0%N/A0.7 $45.63
6/30/20214,000 shares $190,160.00 +110.5%N/A0.8 $47.54
6/15/20211,900 shares $85,747.00 -24.0%N/A0.5 $45.13
5/28/20212,500 shares $112,675.00 +316.7%N/A0.7 $45.07
5/14/2021600 shares $23,895.54 -80.0%N/A0.2 $39.83
4/30/20213,000 shares $124,170.00 +100.0%N/A0.7 $41.39
4/15/20211,500 shares $55,561.50 +200.0%N/A0.3 $37.04
3/31/2021500 shares $18,328.45 -76.2%N/A0.1 $36.66
3/15/20212,100 shares $76,251.00 -43.2%N/A0.4 $36.31
2/26/20213,700 shares $140,315.10 -80.0%N/A0.6 $37.92
2/12/202118,500 shares $754,060.00 +270.0%N/A3.4 $40.76
1/29/20215,000 shares $181,775.00 +4,900.0%N/A1.1 $36.36
1/15/2021100 shares $3,510.38 No ChangeN/A0 $35.10
9/15/2020500 shares $15,561.55 +150.0%N/A0.1 $31.12
8/31/2020200 shares $6,336.00 -75.0%N/A0 $31.68
8/14/2020800 shares $25,440.00 +60.0%N/A0.2 $31.80
7/31/2020500 shares $16,022.50 -73.7%N/A0.1 $32.05
7/15/20201,900 shares $63,194.00 -20.8%N/A0.3 $33.26
6/30/20202,400 shares $73,416.00 +2,300.0%N/A0.4 $30.59
6/15/2020100 shares $2,832.00 No ChangeN/A0 $28.32
5/29/2020100 shares $2,584.00 -50.0%N/A0 $25.84
5/15/2020200 shares $5,256.00 -77.8%N/A0 $26.28
4/30/2020900 shares $23,103.00 No ChangeN/A0.1 $25.67
4/15/2020900 shares $22,032.00 +800.0%N/A0.1 $24.48
3/31/2020100 shares $2,271.00 -96.9%N/A0 $22.71
Mysterious Gold Leverage Just Announced (Ad)

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

CHNA Short Interest - Frequently Asked Questions

What is Loncar China Biopharma ETF's current short interest?

Short interest is the volume of Loncar China Biopharma ETF shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 500 shares of CHNA short. Learn More on Loncar China Biopharma ETF's current short interest.

How does Loncar China Biopharma ETF's short interest compare to its competitors?
Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.27 billion), Charter Communications, Inc. ($2.66 billion), TC Energy Co. ($2.53 billion), Chesapeake Energy Co. ($1.86 billion), Coinbase Global, Inc. ($1.83 billion), Lucid Group, Inc. ($1.78 billion), T. Rowe Price Group, Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.69 billion), Zoom Video Communications, Inc. ($1.35 billion), and Williams-Sonoma, Inc. ($1.35 billion). View all of the most shorted stocks.

What does it mean to sell short Loncar China Biopharma ETF stock?

Short selling CHNA is an investing strategy that aims to generate trading profit from Loncar China Biopharma ETF as its price is falling. CHNA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Loncar China Biopharma ETF?

A short squeeze for Loncar China Biopharma ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CHNA, which in turn drives the price of the stock up even further.

How often is Loncar China Biopharma ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHNA, twice per month. The most recent reporting period available is September, 30 2022.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CHNA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners